Articles

Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center

The Christie NHS Foundation Trust, Manchester, UK;The University of Manchester, Manchester, UK
The Christie NHS Foundation Trust, Manchester, UK;The University of Manchester, Manchester, UK
The Christie NHS Foundation Trust, Manchester, UK
The Christie NHS Foundation Trust, Manchester, UK
The Christie NHS Foundation Trust, Manchester, UK;The University of Manchester, Manchester, UK
The Christie NHS Foundation Trust, Manchester, UK;The University of Manchester, Manchester, UK
The Christie NHS Foundation Trust, Manchester, UK;The University of Manchester, Manchester, UK
Vol. 98 No. 4 (2013): April, 2013 https://doi.org/10.3324/haematol.2012.069393